pirenzepine has been researched along with Hyperplasia in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jewell, LD | 1 |
| Yacoub, W | 1 |
| Salkie, ML | 1 |
| Sherbaniuk, R | 1 |
| Walker, K | 1 |
| Mahachai, V | 1 |
| Kirdeikis, P | 1 |
| Simpson, I | 1 |
| Zuk, L | 1 |
| Brunet, MK | 1 |
1 other study available for pirenzepine and Hyperplasia
| Article | Year |
|---|---|
Enprostil reduces G-cell hyperplasia and hypergastrinemia in duodenal ulcer.
Topics: Adult; Cimetidine; Duodenal Ulcer; Enprostil; Gastric Acid; Gastrins; Humans; Hydrogen-Ion Concentra | 1987 |